Since WT mice are resistant to the development of atherosclerotic lesions, to test whether RvT4 regulates macrophage cholesterol efflux in vivo in settings relevant to the human RA we employed the ApoE-/- model that develops metabolic dysfunction and advanced atherosclerosis and combined this with K/BxN serum transfer arthritis. The gene discussed is APOE; the disease is atherosclerosis.